Internal Medicine, Pulmonary Disease · Newark, DE
NPI
1962422469
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
550 Stanton Christiana Rd Ste 103
Newark, DE, 19713
Phone (302) 633-9033
Groups this clinician bills Medicare through
Medicare paid, 2024
$667K
8,189 services
Medicare patients, 2024
1,102
Average age 73
Drug cost, 2024
$1.5M
4,658 prescriptions
Company payments, 2025
$71.19
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hummayun Ismail was code 99233 (hospital e&m - subsequent), 2,409 times for 102 patients. In total Hummayun Ismail billed 8,189 services in 26 codes, and Medicare paid $667K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 2,409 | 102 | $91.23 | $220K |
| 99232 Hospital E&M - Subsequent | Facility | 1,700 | 121 | $59.83 | $102K |
| 99214 Office E&M - Established | Office | 1,550 | 599 | $89.01 | $138K |
| 99213 Office E&M - Established | Office | 360 | 207 | $64.31 | $23K |
| 99454 E&M - Miscellaneous | Office | 331 | 38 | $35.35 | $12K |
| 99457 E&M - Miscellaneous | Office | 254 | 38 | $36.85 | $9,361 |
| 94060 Pulmonary Function Testing | Office | 157 | 157 | $28.70 | $4,506 |
| 94726 Pulmonary Function Testing | Office | 157 | 157 | $39.04 | $6,129 |
| 94729 Pulmonary Function Testing | Office | 157 | 157 | $40.85 | $6,414 |
| 99203 Office E&M - New | Office | 149 | 149 | $78.08 | $12K |
| 99211 Office E&M - Established | Office | 142 | 142 | $16.52 | $2,346 |
| 99223 Hospital E&M - Initial | Facility | 123 | 117 | $132.43 | $16K |
| 99291 Critical Care E&M | Facility | 118 | 22 | $162.17 | $19K |
| 95800 Sleep Study | Office | 117 | 116 | $93.78 | $11K |
| 95810 Sleep Study | Office | 90 | 86 | $473.65 | $43K |
By year: 2022 $699K for 9,146 services; 2023 $743K for 9,008 services; 2024 $667K for 8,189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hummayun Ismail prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 758 prescriptions and refills. In total Hummayun Ismail wrote 4,658 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 758 | 900 | 251 | $23K |
| Breo Ellipta Fluticasone/Vilanterol | 477 | 673 | 104 | $260K |
| Montelukast Sodium Generic | 370 | 639 | 77 | $4,577 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 351 | 468 | 86 | $295K |
| Prednisone Generic | 327 | 489 | 108 | $1,509 |
| Azelastine Hcl Generic | 222 | 338 | 86 | $8,378 |
| Spiriva Handihaler Tiotropium Bromide | 182 | 250 | 41 | $124K |
| Incruse Ellipta Umeclidinium Bromide | 169 | 245 | 34 | $83K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 159 | 235 | 38 | $39K |
| Fluticasone Propionate Generic | 135 | 241 | 44 | $3,136 |
| Ipratropium Bromide Generic | 114 | 129 | 41 | $3,608 |
| Symbicort Budesonide/Formoterol Fumarate | 97 | 139 | 22 | $33K |
| Azithromycin Generic | 89 | 91 | 46 | $1,032 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 84 | 122 | 34 | $18K |
| Tiotropium Bromide Generic | 77 | 117 | 21 | $40K |
Brand drugs: 2,301 claims; generic drugs: 2,357 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hummayun Ismail $71.19 ($71.19 in general payments such as food, travel and fees) from 3 companies. The largest payer was Inspire Medical Systems, Inc. with $57.08.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 2 | $57.08 |
| Grifols USA, LLC | 1 | $14.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.